These results suggest that CYA alleviates ovarian GC pyroptosis by reducing the androgen level in PCOS mice, and then alleviates the release of inflammatory factors IL-18 and IL-1β caused by pyroptosis and inhibits the local chronic inflammatory response in the ovaries. Here, IL18 is linked to polycystic ovary syndrome.